Ann M. Hanly - Apr 1, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Signature
/s/ Sung Lee, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Apr 1, 2024
Transactions value $
-$27,251
Form type
4
Date filed
4/2/2024, 08:58 PM
Previous filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale -$27.3K -2.71K -2.01% $10.05 132K Apr 1, 2024 Direct F1
holding VIR Common Stock 11.5 Apr 1, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F2 The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.